Company Announcements

Investor Presentation via Investor Meet Company

Source: RNS
RNS Number : 4138E
Clontarf Energy PLC
17 September 2024
 

 

17th September 2024

 

Clontarf Energy plc

("Clontarf" or "the Company")

 

RNS: Investor Presentation via Investor Meet Company.


Clontarf Energy Plc (AIM: CLON) is pleased to announce that Chairman and Managing Director, David Horgan will provide a live presentation relating to the Interim Results via Investor Meet Company on 20 Sept 2024, 10:00 BST.


The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 19 Sept 2024, 09:00 BST, or at any time during the live presentation.


Investors can sign up to Investor Meet Company for free and add to meet Clontarf Energy Plc via:


 https://www.investormeetcompany.com/clontarf-energy-plc/register-investor


Investors who already follow Clontarf Energy Plc on the Investor Meet Company platform will automatically be invited.

 

 

ENDS

 

 

For further information please visit http://clontarfenergy.com or contact:

 

Clontarf Energy

David Horgan, Chairman

Jim Finn, Director

 

+353 (0) 1 833 2833

Nominated & Financial Adviser

Strand Hanson Limited

Rory Murphy

Ritchie Balmer

 

 

+44 (0) 20 7409 3494

Broker

Novum Securities Limited

Colin Rowbury

        +44 (0) 207 399 9400





Public Relations

BlytheRay

Megan Ray

 

 

+44 (0) 207 138 3204

 

Teneo

Luke Hogg

Alan Tyrrell

Fia Long

Alan Reynolds

+353 (0) 1 661 4055

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADGGDCUGBDGSL